PTEN and cancer: To clarify the problems concerning PTEN evaluation, it would be necessary a comparison of the results obtained by analyzing the several PTEN alterations through different methodologies (FISH, promoter methylation, LOH, and immunohistochemistry performed with different antibodies) both on cancer cell lines with a well known PTEN status and on a large series of patients in order to better establish IHC evaluation criteria.